Perceptions of prostate cancer patients undergoing definitive radiotherapy on the impact of prostate cancer and radiation therapy on male sexuality

被引:0
|
作者
Daniels, Joseph [1 ]
Baffoe-Krapim, Leroy [1 ,2 ]
Nyantakyi, Andrew Yaw [1 ]
Ayabilah, Edwina Ayaaba [1 ]
Tackie, Judith Naa Odey [1 ]
Kyei, Kofi Adesi [1 ,2 ]
机构
[1] Korle Bu Teaching Hosp, Natl Radiotherapy Oncol & Nucl Med Ctr, Accra, Ghana
[2] Univ Ghana, Dept Radiog, Accra, Ghana
来源
ECANCERMEDICALSCIENCE | 2024年 / 18卷
关键词
radiotherapy; prostate cancer; erectile dysfunction; premature ejaculation; sexual function; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; MEN; SYMPTOMS; RISK;
D O I
10.3332/ecancer.2024.1726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Male sexual function is an important aspect of the life of prostate cancer patients and plays a significant role in the long-term quality of life of prostate cancer survivors. However, there is a paucity of published literature on the perceived impact of prostate cancer and its treatment on the sexual function of patients in Ghana and West Africa in general. The purpose of this study was to explore the perceptions of prostate cancer patients on the effects of the disease and radiation therapy on male sexual function. The study also examined the changes in sexuality experienced by men with prostate cancer. Methods: This research was a descriptive longitudinal study conducted at the third largest hospital in Africa. The study included Ghanaian prostate cancer patients of all ages who were treated with definitive radiotherapy at the study site between October 2021 and May 2022. Quantitative data were collected and analysed using the Statistical Package for Social Sciences version 26.0 and Microsoft Excel 2019. Descriptive statistics were used to determine frequencies and percentages of the demographic characteristics. Results: The mean age of the participants was 65.7 years (SD 6.7) ranging from 50 to 81 years. Patients had different ideas about the potential adverse effects of prostate cancer (86%) and radiotherapy (70%) on male sexual function. A decrease in sexual desire (54%) was the commonest perceived effect of prostate cancer on male sexual function followed by premature ejaculation (49%) and a decrease in sexual activity (48%). On the other hand, erectile dysfunction (49%) was the commonest perceived effect of radiotherapy for prostate cancer on male sexual function followed by a decrease in sexual desire (38%) and premature ejaculation (37%). Health professionals were the major source of information regarding the perceptions of the patients on the effects of both prostate cancer (46%) and radiation therapy (43%) on male sexual function. Conclusion: There should be enhancement of awareness measures to educate Ghanaian cancer patients on the side effects and implications of treatment on their sexuality. Comprehensive sexual health assessment should be incorporated in the routine care of patients with cancers that have the potential to impact the sexual function of patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy
    Sherer, Michael, V
    Deka, Rishi
    Salans, Mia A.
    Nelson, Tyler J.
    Sheridan, Paige
    Rose, Brent S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 276 - 281
  • [2] Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy
    Michael V. Sherer
    Rishi Deka
    Mia A. Salans
    Tyler J. Nelson
    Paige Sheridan
    Brent S. Rose
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 276 - 281
  • [3] Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (05): : 496 - 503
  • [4] Prostate Brachytherapy: The "Can't Miss" Approach for Patients Undergoing Definitive Radiation for Prostate Cancer?
    Krauss, Daniel J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03): : 575 - 576
  • [5] Endocrine therapy for recurrence after definitive radiotherapy in patients with prostate cancer
    Furuya, Y
    Akakura, K
    Tanaka, M
    Ichikawa, T
    Igarashi, T
    Murakami, S
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (05) : 222 - 226
  • [6] Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer
    Mendenhall, William M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Nichols, Romaine Charles
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 530 - 534
  • [7] Prognostic and Therapeutic Implications of PNI in Prostate Cancer Patients Undergoing Definitive Radiation
    Robertson, S. P.
    Narang, A. K.
    Ram, A. N.
    He, P.
    Griffith, E.
    Singh, H.
    DeWeese, T. A.
    Honig, S.
    McNutt, T. R.
    Tran, P. T.
    DeWeese, T. L.
    Song, D. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S460 - S460
  • [8] Prognostic Value of PSA Nadir in Patients Undergoing Definitive Radiation for Prostate Cancer
    Ram, A. N.
    Robertson, S. P.
    Narang, A. K.
    Hei, P.
    Griffith, E.
    Singh, H.
    DeWeese, T. A.
    Honig, S.
    McNutt, T. R.
    DeWeese, T. L.
    Song, D. Y.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S456 - S456
  • [9] The Impact of Radiation Cost on Patient Outcomes After Definitive Radiation Therapy in Prostate Cancer
    Fero, K. E.
    Paravati, A. J.
    Panjwani, N.
    Boero, I. J.
    Hwang, L.
    Matsuno, R. K.
    Murphy, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S161 - S161
  • [10] Micronuclei in lymphocytes of prostate cancer patients undergoing radiation therapy
    Lee, TK
    O'Brien, KF
    Naves, JL
    Christie, KI
    Arastu, HH
    Eaves, GS
    Wiley, AL
    Karlsson, UL
    Salehpour, MR
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2000, 469 (01) : 63 - 70